Want to see SRXH full AI Analyst Report?
SRXH Stock Chart & Stats
$1.80
-$0.21(-11.67%)
At close: 4:00 PM EDT
$1.80
-$0.21(-11.67%)
Day’s Range― - ―
52-Week Range$0.96 - $42.70
Previous Close$1.59
Volume1.23M
Average Volume (3M)7.54M
Market Cap
$36.68M
Enterprise Value$12.46
Total Cash (Recent Filing)$42.69M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.27
Next Earnings
May 20, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.04%
Share Statistics
EPS (TTM)-79.04
Shares Outstanding20,265,390
10 Day Avg. Volume4,569,660
30 Day Avg. Volume7,542,317
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)22.88
Price to Sales (P/S)1.43
P/FCF Ratio-1.14
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.32
Revenue Forecast (FY)$95.00M
Bulls Say, Bears Say
Bulls Say
Improved Balance SheetZero reported debt and substantial equity capitalization reduce near-term solvency risk and provide more flexibility to fund operations. This is a meaningful improvement from prior leverage, although sustained returns and cash generation still need to improve.
Exchange Listing ComplianceRestored compliance removes a material structural threat to the company’s exchange presence and improves operating continuity for investors, employees and counterparties. Maintaining compliance should reduce administrative disruption and preserve access to public-market financing.
Fresh Capital InfusionApproximately $8 million of new funding strengthens liquidity and gives management additional resources to support operations and strategic initiatives. The proceeds may reduce immediate dependence on distressed financing, provided capital is deployed toward cash-generating activities.
Bears Say
Persistent Cash BurnDeeply negative free cash flow indicates that the business is not currently self-funding and may require additional capital to sustain operations or execute its strategy. Repeatedly weak cash conversion increases financing dependence and limits financial flexibility.
Unstable ProfitabilityRecurring losses and sharply swinging margins make earnings power difficult to establish and weaken confidence in the underlying operating model. The negative TTM revenue base further complicates trend interpretation, raising execution and reporting-quality risks.
Dilutive Financing StructureConvertible preferred financing and extensive warrant issuance can dilute existing holders and create future claims on equity. Combined with prior leverage volatility and recapitalizations, this suggests the company remains reliant on external capital rather than durable internal funding.
SRx Health Solutions News
SRXH FAQ
What was SRx Health Solutions’s price range in the past 12 months?
SRx Health Solutions lowest stock price was $0.96 and its highest was $42.70 in the past 12 months.
What is SRx Health Solutions’s market cap?
SRx Health Solutions’s market cap is $36.68M.
When is SRx Health Solutions’s upcoming earnings report date?
SRx Health Solutions’s upcoming earnings report date is May 20, 2027 which is in 267 days.
How were SRx Health Solutions’s earnings last quarter?
SRx Health Solutions released its earnings results on Aug 13, 2026. The company reported -$0.362 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is SRx Health Solutions overvalued?
According to Wall Street analysts SRx Health Solutions’s price is currently Overvalued.
Does SRx Health Solutions pay dividends?
SRx Health Solutions pays a Notavailable dividend of $0.05 which represents an annual dividend yield of 3.04%. See more information on SRx Health Solutions dividends here
What is SRx Health Solutions’s EPS estimate?
SRx Health Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SRx Health Solutions have?
SRx Health Solutions has 20,265,390 shares outstanding.
What happened to SRx Health Solutions’s price movement after its last earnings report?
SRx Health Solutions reported an EPS of -$0.362 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.918%.
Which hedge fund is a major shareholder of SRx Health Solutions?
Currently, no hedge funds are holding shares in SRXH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SRx Health Solutions Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
SRXH Sentiment 100%
Sector Average 56%
Sector Average 56%
Hedge Fund Trend
Decreased
By 333.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.5%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-93.43%
12-Months-Change
Fundamentals
Return on Equity
3.04%
Trailing 12-Months
Asset Growth
327.71%
Trailing 12-Months
Company Description
SRx Health Solutions
SRX Global Inc. develops artificial intelligence (AI)-powered solutions designed to improve decision-making, streamline operations, and strengthen risk management. The company is headquartered in Tampa, Florida.
SRXH Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant improvements in profitability measures, including gross profit margins, net loss, and EBITDA. Revenue growth, particularly in the fourth quarter and international markets, was strong. However, there were challenges such as a decline in annual net revenues and ongoing EBITDA losses. Overall, the company's strategic pivots and financial health improvements contributed to a positive outlook.View all SRXH earnings summariesTechnical Analysis
Grifols SA
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
MIRA Pharmaceuticals, Inc.
―
Ownership Overview
8.07% Insiders
0.54% Mutual Funds
0.10% Other Institutional Investors
90.72% Public Companies and
Individual Investors